Hydroxychloroquine Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI4629

Summary Methodology

Global hydroxychloroquine market size is anticipated to witness gains in the forecasted timespan owing to its applications in the pharmaceutical sector. The product is used for treating and preventing malaria which is caused by mosquito bite. It is also used in treatment of auto immune diseases including rheumatoid arthritis and lupus. The product is recently being studied for the treatment of coronavirus spread which will foster overall industry growth.

Hydroxychloroquine is the basic raw material which is used for preparing tablets and are sold under the brand name of Plaquenil. It is a white crystalline powder which is soluble in water. The product has a weak basic nature and effects the parasite’s acidic vesicles and inhibits heme polymerization thereby aiding malaria treatments. According to World malaria report 2019, pregnant women and young children are more vulnerable to malaria.

In 2018, more than 225 million malaria cases occurred globally. Most of these cases were reported in Africa followed by the South East Asian region. Hydroxychloroquine is widely used in the treatment of malaria owing to its tendency to concentrate in parasite’s acidic vesicles. Global antimalarial drugs industry is anticipated to witness significant gains over 4.5% by the end of 2026. Rising malaria cases globally owing to lack of sanitation resulting to more breeding of mosquitos will have a positive impact on hydroxychloroquine market share.

Hydroxychloroquine owing to its pain and swelling reducing properties is used to cure rheumatoid arthritis. It also helps in the prevention of joint damage and decrease probability of long term disability. It is estimated that more than 150 million people were suffering from rheumatoid arthritis globally in 2017. Increasing R & D activities and treatments to cure diseases in order to prevent long term disabilities will stimulate hydroxychloroquine market growth.

Researchers are conducting activities to test the product for the treatment of coronavirus spread as it has shown positive results in case of some patients. The product can hinder the immune system of human being from functioning overboard in order to attack the virus. Hydroxychloroquine helps to calm the human being’s immune system response. As per the research, the product protects the laboratory grown cells from the coronavirus and its effects is being studied by the scientists in case of human trials. Rising hydroxychloroquine demand in order to conduct clinical trials along with the treatments of autoimmune diseases and malaria will have a positive impact on hydroxychloroquine market.

Coronavirus cases are rising continuously which has led to utilization of current available drugs. The spread has led to more than 134,669 casualties and over 2,080,042 infections globally. Majorly hit countries include U.S., Italy, Spain and China. On March 24th, 2020 research scientists at NYU Langone launched largest hydroxychloroquine studies in order to determine the hydroxychloroquine’s effect on coronavirus. Rising coronavirus cases globally may foster the demand of the hydroxychloroquine drug in order to treat the patients.

Hydroxychloroquine, owing to disease activity control and cardiovascular issues prevention is used to treat lupus which is an autoimmune disease and affects body organs. The disease has affected more than 23.5 million people in the U.S. Increasing R & D activities and advancements in the pharmaceutical sector in order to treat such diseases will have a positive impact on hydroxychloroquine market value.

North America driven by Canada, Mexico, and U.S. is anticipated to witness significant gains by 2026. India which is a major producer and exporter of hydroxychloroquine has already exported more than 3.5 million tablets along with more than 8.5 metric tons of ingredient to United states for treatment of coronavirus. U.S. has till now reported more than 644 thousand confirmed coronavirus cases. Large number of clinical trials and rising coronavirus cases will lead to increased consumption of the product in the region, thus fostering the hydroxychloroquine market.

India is exporting hydroxychloroquine to several countries other than U.S., which includes Nepal, Bhutan, Malaysia, and Sri Lanka to curb growth of coronavirus pandemic. These factors will lead to increase in demand of the drug globally which will stimulate hydroxychloroquine market.

Global hydroxychloroquine industry share is moderately fragmented with major companies including Intas Pharmaceuticals, McW Healthcare of Indore, Macleods Pharmaceuticals, Cipla,  Novartis International AG, Sanofi S.A., Amneal Pharmaceuticals, Inc., Covis Pharmaceuticals, Inc., Laurus Labs Limited, and  Lupin Pharmaceuticals, Inc. Manufacturers are focusing on capacity expansion by implementing strategic decisions including collaborations and partnerships. On March 30th, 2020 Intas informed about its collaboration on WHO endorsed studies on studying the effect of the hydroxychloroquine on coronavirus.

Pharmaceutical companies including Zydas and Ipca are planning to increase their production capacities by 6 times in order to fulfil the domestic and international demand. Ipca labs and Zydus have implemented backward integration in the hydroxychloroquine manufacturing capabilities. Aforementioned factors will stimulate the production of the product which will have a positive impact on hydroxychloroquine market growth.

By Function, 2015-2026 (Tons) (USD Million)

  • Rheumatied Arthritis
  • Lucus
  • Malaria
  • Others (Coronavirus and Porphyria Cutanea Tarda)

By Application, 2015-2026 (Tons) (USD Million)

  • Injectables
  • Tablets

The above information is provided on a regional and country basis for the following:

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Spain
    • Poland
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Malaysia
    • Australia
    • Indonesia
    • Brazil
  • MEA
    • Saudi Arabia
    • UAE
    • South Africa


Company Profiles:

  • Intas Pharmaceuticals
  • McW Healthcare of Indore
  •  Macleods Pharmaceuticals
  • Cipla
  •  Novartis International AG
  • Sanofi S.A.
  • Amneal Pharmaceuticals, Inc.
  • Laurus Labs Limited
  • Covis Pharmaceuticals, Inc.

What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X